Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis

Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis

Tigecycline is a novel glycylcycline broad-spectrum antibiotic offering good coverage for critically ill patients experiencing complicated infections. A known side effect is a coagulation disorder with distinct hypofibrinogenemia. To date, the information on possible risk factors and outcomes is spa...

Full description

Bibliographic Details
Main Authors: Benedikt Treml, Sasa Rajsic, Tobias Hell, Dietmar Fries, Mirjam Bachler
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
antibiotics
coagulation disorder
coagulopathy
glycylcycline
hypofibrinogenemia
infection
Online Access:https://www.mdpi.com/2077-0383/10/20/4702

Internet

https://www.mdpi.com/2077-0383/10/20/4702

Similar Items